Barclays’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-1,300
| Closed | -$3K | – | 7320 |
|
|
2017
Q2 | $3K | Sell |
1,300
-1,300
| -50% | -$2.99K | ﹤0.01% | 6391 |
|
|
2017
Q1 | $6K | Sell |
2,600
-5,500
| -68% | -$12.2K | ﹤0.01% | 6257 |
|
|
2016
Q4 | $17K | Sell |
8,100
-2,000
| -20% | -$5.58K | ﹤0.01% | 5720 |
|
|
2016
Q3 | $34K | Sell |
10,100
-47,800
| -83% | -$152K | ﹤0.01% | 5211 |
|
|
2016
Q2 | $182K | Sell |
57,900
-17,100
| -23% | -$57K | ﹤0.01% | 3983 |
|
|
2016
Q1 | $225K | Buy |
75,000
+49,500
| +194% | +$154K | ﹤0.01% | 3759 |
|
|
2015
Q4 | $77K | Buy |
25,500
+19,700
| +340% | +$82.5K | ﹤0.01% | 4568 |
|
|
2015
Q3 | $29K | Sell |
5,800
-5,500
| -49% | -$31.5K | ﹤0.01% | 5307 |
|
|
2015
Q2 | $68K | Sell |
11,300
-11,700
| -51% | -$78.4K | ﹤0.01% | 4962 |
|
|
2015
Q1 | $161K | Buy |
23,000
+3,000
| +15% | +$21.7K | ﹤0.01% | 4510 |
|
|
2014
Q4 | $140K | Sell |
20,000
-4,000
| -17% | -$31.7K | ﹤0.01% | 4918 |
|
|
2014
Q3 | $168K | Buy |
24,000
+7,200
| +43% | +$66.8K | ﹤0.01% | 4904 |
|
|
2014
Q2 | $151K | Sell |
16,800
-236,700
| -93% | -$2.11M | ﹤0.01% | 5104 |
|
|
2014
Q1 | $2.03M | Hold |
253,500
| – | – | ﹤0.01% | 2534 |
|
|
2013
Q4 | $2.03M | Buy |
253,500
+83,300
| +49% | +$702K | ﹤0.01% | 2656 |
|
|
2013
Q3 | $1.19M | Sell |
170,200
-500
| -0.3% | -$4.02K | ﹤0.01% | 3160 |
|
|
2013
Q2 | $1.32M | Buy |
+170,700
| New | +$1.33M | ﹤0.01% | 3031 |
|
